General form of registration statement for all companies including face-amount certificate companies

Stock-Based Compensation (Tables)

v3.19.1
Stock-Based Compensation (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of RSA activity

 

 

Number of

Shares

 

 

Weighted

Average Grant

Date Fair Value

 

Unvested, December 31, 2018

 

 

900,000

 

 

$ 0.19

 

 

 

 

 

 

 

 

 

 

Granted

 

 

-

 

 

 

-

 

Released

 

 

(450,000 )

 

 

0.19

 

Unvested, March 31, 2019

 

 

450,000

 

 

$ 0.19

 

 
Stock options | Omnibus Incentive Plan 2014    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of shares available for future grant  

 

 

Shares Available for Grant

 

Available as of December 31, 2017

 

 

870,000

 

Share pool increase

 

 

10,190,774

 

Forfeited

 

 

427,000

 

Expired

 

 

48,000

 

Granted

 

 

(2,393,501 )

Available as of December 31, 2018

 

 

9,142,273

 

Schedule of summary of stock option activity  

 

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

 

 

Weighted

Average Remaining

Contractual

Term

(Years)

 

 

Aggregate Intrinsic Value*

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding, December 31, 2017

 

 

1,130,000

 

 

$ 0.60

 

 

 

6.89

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

1,750,000

 

 

 

0.30

 

 

 

 

 

 

 

 

Expired

 

 

(48,000 )

 

 

2.57

 

 

 

 

 

 

 

 

Forfeited

 

 

(427,000 )

 

 

0.66

 

 

 

 

 

 

 

 

Outstanding, December 31, 2018

 

 

2,405,000

 

 

$ 0.33

 

 

 

8.71

 

 

$ 182,000

 

Exercisable, December 31, 2018

 

 

859,417

 

 

$ 0.37

 

 

 

7.39

 

 

$ 36,458

 

Vested and Expected to Vest, December 31, 2018

 

 

2,405,000

 

 

$ 0.33

 

 

 

8.71

 

 

$ 182,000

 

 

*The aggregate intrinsic value is the sum of the amounts by which the quoted market price of the Company’s stock exceeded the exercise price of the stock options at December 31, 2018 for those stock options for which the quoted market price was in excess of the exercise price (“in-the-money options”).
Schedule of fair value assumptions of stock option granted  

 

 

Year Ended

December 31, 2018

 

Dividend Yield

 

 

 

Risk-free interest rate

 

3.06 – 3.1

Expected term (in years)

 

5.27-5.58

 

Volatility

 

70-93.6

%

Stock options | Awards Granted Outside the 2014 Plan    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of fair value assumptions of stock option granted  

 

 

At Issuance

 

Dividend Yield

 

 

 

Risk-free interest rate

 

 

2.79 %

Expected term (in years)

 

 

5.54

 

Volatility

 

 

70 %
Restricted Stock Awards | Omnibus Incentive Plan 2014    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of RSA activity  

 

 

Number of

Shares

 

 

Weighted

Average Grant

Date Fair Value

 

Unvested, December 31, 2017

 

 

1,050,000

 

 

$ 0.75

 

 

 

 

 

 

 

 

 

 

Granted

 

 

643,501

 

 

 

0.26

 

Released

 

 

(1,050,000 )

 

 

0.75

 

Unvested, December 31, 2018

 

 

643,501

 

 

$ 0.26

 

Restricted Stock Awards | Awards Granted Outside the 2014 Plan    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of RSA activity  

 

 

Number of

Shares

 

 

Weighted

Average Grant

Date Fair Value

 

Unvested, December 31, 2017

 

 

-

 

 

$ -

 

 

 

 

 

 

 

 

 

 

Granted

 

 

2,500,000

 

 

 

0.19

 

Released

 

 

(1,600,000 )

 

 

0.19

 

Unvested, December 31, 2018

 

 

900,000

 

 

$ 0.19